Ask Warren

Reyon Pharmaceutical

102460 · KOSPI · ₩102460 · 이연제약

₩9,720▼ ₩10 (0.10%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

20252024202320222021
Revenue₩146B₩148B₩151B₩154B₩143B
Cost of sales₩108B₩76B₩72B₩72B₩63B
Gross profit₩38B₩73B₩79B₩82B₩79B
Operating income−₩30B₩79M₩4B₩9.6B₩3.7B
Net income−₩30B₩4.2B₩3.6B₩7.4B₩5.5B
Net income to shareholders−₩30B₩4.2B₩3.6B₩7.4B₩5.5B

Balance sheet

20252024202320222021
Total assets₩465B₩500B₩500B₩485B₩478B
Current assets₩80B₩89B₩100B₩109B₩165B
Cash and equivalents₩6.7B₩10B₩24B₩16B₩67B
Total liabilities₩245B₩250B₩251B₩237B₩233B
Current liabilities₩143B₩136B₩126B₩48B₩48B
Borrowings₩99B₩89B₩101B₩23B₩23B
Total equity₩220B₩250B₩249B₩248B₩245B
Shareholders' equity₩220B₩250B₩249B₩248B₩245B

Cash flow

20252024202320222021
Cash from operations₩1.5B−₩1.4B₩8.6B₩8.7B₩12B
Capital spending−₩7.9B−₩16B−₩29B−₩63B−₩117B
Free cash flow−₩6.5B−₩17B−₩20B−₩54B−₩105B
Dividends paid₩0₩2.8B₩2.7B₩4.6B₩3.5B

Consolidated where available. Amounts in won.

Also known as: Reyon Pharmaceutical / 이연제약 / 102460 / KRX:102460

Source: KRX statistical information